Bupropion reduces food cravings and the reward value of food
4 Accordingly, the manufacturer prescribing information for all currently available GLP-1 RAs includes a warning for increased risk of hypoglycemia when used in combination with an insulin secretagogue or insulin 5-11 and state that reducing the dose of the insulin secretagogue or insulin may be necessary to prevent hypoglycemia
Benefits &
Everything in Protocol 1, plus: Protein supplement: Increase to 1.6-2.0 g/kg total daily protein (likely requires 40-80 grams from supplements) Creatine monohydrate: 5 grams daily HMB: 3 grams daily Omega-3 fish oil: 1-2 grams EPA/DHA daily Expected benefits: Significantly reduced lean mass loss, maintained or improved strength, better metabolic rate preservation, improved body composition outcomes
Could medications designed for glycemic control also help reduce uric acid levels
This article examines the compatibility of semaglutide and thyroid medication, addressing FDA warnings, monitoring requirements, and practical considerations for patients taking both therapies concurrently
